<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Autoimmune &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tech-bio-category/autoimmune/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 04 Mar 2025 02:01:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>Autoimmune &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Use of Synthetic Mucus to Reduce Inflammation in Inflammatory Bowel Disease (IBD)</title>
		<link>https://innovate.research.ufl.edu/tech-bio/use-of-synthetic-mucus-to-reduce-inflammation-in-inflammatory-bowel-disease-ibd/</link>
		
		<dc:creator><![CDATA[Alex Ganz]]></dc:creator>
		<pubDate>Tue, 04 Mar 2025 02:01:23 +0000</pubDate>
				<guid isPermaLink="false">https://scaddev1.com/?post_type=tech-bio&#038;p=2916</guid>

					<description><![CDATA[Improving gut barrier function and reducing intestinal permeability Administer ultra-high molecular weight polymers as synthetic mucus to reduce microbes contact with epithelium]]></description>
										<content:encoded><![CDATA[<ul class="wp-block-list">
<li>Improving gut barrier function and reducing intestinal permeability</li>
<li>Administer ultra-high molecular weight polymers as synthetic mucus to reduce microbes contact with epithelium</li>
</ul>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Dissociated Glucocorticoids With Improved Effects in Skeletal Muscle</title>
		<link>https://innovate.research.ufl.edu/tech-bio/dissociated-glucocorticoids-with-improved-effects-in-skeletal-muscle/</link>
		
		<dc:creator><![CDATA[Alex Ganz]]></dc:creator>
		<pubDate>Tue, 04 Mar 2025 02:01:06 +0000</pubDate>
				<guid isPermaLink="false">https://scaddev1.com/?post_type=tech-bio&#038;p=2914</guid>

					<description><![CDATA[Two novel glucocorticoids with reduced side effects Used to treat various inflammatory and autoimmune conditions effectively One of the compounds shows promise in treating cachexia]]></description>
										<content:encoded><![CDATA[<ul class="wp-block-list">
<li>Two novel glucocorticoids with reduced side effects</li>
<li>Used to treat various inflammatory and autoimmune conditions effectively</li>
<li>One of the compounds shows promise in treating cachexia</li>
</ul>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>REV-ERB Agonists</title>
		<link>https://innovate.research.ufl.edu/tech-bio/rev-erb-agonists/</link>
		
		<dc:creator><![CDATA[Alex Ganz]]></dc:creator>
		<pubDate>Tue, 04 Mar 2025 02:00:46 +0000</pubDate>
				<guid isPermaLink="false">https://scaddev1.com/?post_type=tech-bio&#038;p=2912</guid>

					<description><![CDATA[Treatment of TH17-mediated autoimmune and inflammatory disorders MS, psoriasis, IBD In vivo testing in EAE and psoriasis models Pre-clinical candidate selection]]></description>
										<content:encoded><![CDATA[<ul class="wp-block-list">
<li>Treatment of TH17-mediated autoimmune and inflammatory disorders</li>
<li>MS, psoriasis, IBD</li>
<li>In vivo testing in EAE and psoriasis models</li>
<li>Pre-clinical candidate selection</li>
</ul>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
